⚠️ Research/education only. Statements about this compound haven’t been evaluated by the FDA; it isn’t intended to diagnose, treat, cure, or prevent disease.
Tirzepatide
Peptide Bottle
$150.00
- C225H348N48O68
- 39 aa
- Lyophilized powder
A 39-residue synthetic peptide structurally derived from the human GIP sequence, incorporating Aib residues and a C20 fatty-diacid side chain that confers co-agonist activity at both the GIP receptor and GLP-1 receptor. It is investigated in preclinical and in-vitro model systems as a tool compound for characterizing dual incretin-receptor pharmacology and downstream signaling.
50mg
Quantity
⚠️ FDA hasn’t evaluated our statements; efficacy isn’t confirmed by FDA—products aren’t intended to diagnose, treat, cure, or prevent disease.